The AMA Voted to Undo RFK Jr.’s Peptide Policy. Medspas Offering BPC-157 Are Building on a Policy That Can Disappear With One Memo.
Published on: 19/11/2026
The AMA voted to urge HHS to rescind RFK Jr.'s peptide policy. What it means for medspas offering BPC-157, and why the policy can disappear with one memo.
AMA peptide policyBPC-157TB-500compounded peptidesHHS enforcement discretionRFK Jr. peptidespeptide compounding503A compoundingunapproved peptidesmedspa peptidesHims & Hers peptidesFDA Pharmacy Compounding Advisory Committeestate medical board peptidesmedspa complianceMedSpa Board certification
